"Nearly 7 years after her first attempt to test Ebola prevention drugs, Jaspard is stunned by the sudden interest in the trial. “I've kept this project for all these years, despite the fact that a lot of people were saying it's not useful, you don't need to do this, go away,” she #Ebola #ClinicalTrials #MedicalResearch #Therearenospecificcountryreferencesinthetweetprovided.
One glimmer of hope in the Ebola response: Within hours of the outbreak in DRC being declared, researchers convened to prepare drug trials. A lot has changed on that front since the Ebola outbreak in West Africa a decade ago. But huge challenges remain… My story in #Ebola #DRC #MedicalResearch #CD #GW
Maria Patzwald, a 38-year-old woman diagnosed with severe preeclampsia during her second pregnancy, participated in a pioneering clinical trial that targeted a specific protein believed to cause the condition, leading to a significant extension of her pregnancy by 10 days and an increased survival chance for her premature son. #Pregnancy #Preeclampsia #MedicalResearch #US #DE #GB
A 38-year-old woman named Maria Patzwald participated in a pioneering trial aimed at treating preeclampsia, a potentially fatal pregnancy complication, and her involvement helped extend her son's gestation by two weeks, significantly improving his chances of survival. #PregnancyCare #MedicalResearch #PreEclampsia #US #DE #GB
A 38-year-old woman, Maria Patzwald, participated in a pioneering trial for treating preeclampsia, a serious pregnancy complication, which helped extend her pregnancy by ten days, allowing her son Bennet to be born at 34 weeks, significantly improving his chances of a healthy outcome. #Pregnancy #Preeclampsia #MedicalResearch #US #DE #GB
The Wound Innovation Institute in Hull, a new £48m research facility, aims to transform the treatment of chronic wounds by bringing together researchers, NHS clinicians, and industry partners to develop innovative therapies, addressing a significant clinical need that costs the NHS £8.3bn annually. #WoundCare #MedicalResearch #Innovation #GB
The newly opened £48 million Wound Innovation Institute in Hull aims to revolutionize treatment for chronic wounds by uniting researchers, NHS clinicians, and industry partners to develop innovative therapies, addressing a critical clinical need that costs the NHS £8.3 billion annually. #WoundCare #MedicalResearch #HealthcareInnovation #GB
The newly established £48 million Wound Innovation Institute in Hull aims to revolutionize the treatment of chronic wounds by collaborating with academics, NHS clinicians, and industry partners to research their causes and develop innovative therapies, with significant funding support from both private companies and government grants. #WoundCare #MedicalResearch #HealthcareInnovation #GB
The Wound Innovation Institute at the University of Hull, supported by £48m in funding, aims to revolutionize the treatment of chronic wounds through research collaborations that promise to significantly improve patient outcomes and reduce NHS costs. #WoundCare #MedicalResearch #HealthcareInnovation #GB
The newly opened £48m Wound Innovation Institute in Hull aims to transform the treatment of chronic wounds by collaborating with academics, NHS clinicians, and industry partners to develop innovative therapies and advance research in the field, addressing a significant area of unmet clinical need. #WoundCare #MedicalResearch #HealthcareInnovation #GB
(TR) Besides pancreatic adenocarcinoma, what is the other cursed tumor that has taken away my dearest people? Glioblastoma. And here I am talking about the Andes virus while science is just taking its first steps against this murderer!
An international consortium has renamed polycystic ovary syndrome (P.C.O.S.) to polyendocrine metabolic ovarian syndrome (P.M.O.S.) to more accurately reflect its complex hormonal and metabolic effects, aiming to improve diagnosis, treatment, and funding for the condition, which affects 10-13% of reproductive-age women. #WomensHealth #EndocrineDisorders #MedicalResearch #AU #US
In a significant breakthrough for pancreatic cancer treatment, the experimental drug daraxonrasib has shown promise in prolonging patient survival by targeting a previously deemed untreatable protein, KRAS, marking a potential turning point in the battle against this deadly disease after decades of failed treatments and research. #PancreaticCancer #MedicalResearch #CancerTreatment #US #CA
The University of Aberdeen has secured over £1 million in funding from the British Heart Foundation to further develop Trodusquemine, a promising drug that has shown potential in reducing fat in arteries and lowering "bad cholesterol," with hopes of advancing to human clinical trials to aid those suffering from severe atherosclerosis. #HeartDisease #MedicalResearch #CholesterolTreatment #GB #DK #FR #NL
Patients at Birmingham's Queen Elizabeth Hospital are receiving innovative CAR-T cell therapy, a revolutionary treatment for B-cell acute lymphoblastic leukaemia, offering hope and improved outcomes for those previously unsuccessful with traditional chemotherapy. #CancerTreatment #HealthcareInnovation #MedicalResearch #GB
Recent research has unveiled the existence of a third circulatory system in the human body, known as the interstitium, which comprises interconnected pathways that facilitate the movement of fluids, cells, and molecules between tissues, suggesting a deeper complexity to human anatomy that aligns with ancient knowledge in traditional Chinese medicine. #HumanBody #MedicalResearch #CirculatorySystem #IT #GB #US #CN
Scientists have discovered a potential third circulatory system in the human body, called the interstitium, which consists of interconnected spaces that allow fluids, cells, and molecules to move between tissues, challenging our understanding of human physiology and echoing concepts found in traditional Chinese medicine. #HumanBody #MedicalResearch #CirculatorySystem #IT #GB
The New York Times reported that the FDA halted the publication of two significant studies confirming the safety of Covid-19 vaccines, which has sparked controversy regarding the Trump administration's vaccination policies and has raised concerns about political interference in scientific research, particularly in light of Robert F. Kennedy Jr.'s controversial role in health policy. #Vaccines #PublicHealth #MedicalResearch #US
The New York Times reported that the FDA has stopped the publication of studies confirming the safety of certain vaccines, igniting controversy over Trump's administration's vaccination policies and raising concerns about political influence on medical research, especially amid the appointment of Robert F. Kennedy Jr. as health secretary, who has promoted debunked health claims and dismissed key CDC advisory committee members. #Vaccines #PublicHealth #MedicalResearch #US
Investigadores de la Facultad de Medicina de la Universidad de Tohoku en Japón han descubierto que el fármaco lubiprostona, utilizado para tratar el estreñimiento, podría ralentizar la progresión de la enfermedad renal crónica en pacientes, al mejorar la función renal asociada a desequilibrios en la microbiota intestinal. #ChronicKidneyDisease #MedicalResearch #GutHealth
